Company intelligence / Profile preview

Smartest Technologies

Ownership: Private
Development stage: Commercial

Overview

Smartest Technologies is developing a digital health platform enabling comprehensive at-home blood testing, with an initial focus on glucose level monitoring. The company is in early-stage development and aims to address the growing need for remote diagnostics and chronic disease management tools such as diabetes care. No clinical trial results are publicly available yet.

Therapeutic areas: EndocrinologyHematology
Modalities: DeviceDigital health platform
Industry: Physiological Monitoring

Beyond the preview

Go deeper on Smartest Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Smartest Technologies.

Explore the full profile